Search Within

Alumni (GSK)

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (91)
  2. Meeting Abstract (48)
  3. Editorial (2)
  4. Conference Paper (1)
  5. Review (1)
Groups
  1. Epidemiology and Biostatistics (143)
  2. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (143)
  3. GSK Faculty (138)
  4. Department of Medicine (113)
  5. Sloan Kettering Institute Postdocs (108)
  6. Human Oncology and Pathogenesis Program (94)

More Groups

People
  1. Nikolaus Schultz (46)
  2. Michael Berger (38)
  3. David Solit (31)
  4. Marc Ladanyi (26)
  5. Ross Levine (26)
  6. Jianjiong Gao (25)

More People

Years
  1. 2025 (7)
  2. 2024 (15)
  3. 2023 (23)
  4. 2022 (31)
  5. 2021 (12)
  6. 2020 (10)

More Years

Publications
  1. Blood (18)
  2. Cancer Research (17)
  3. Nature (13)
  4. Journal of Clinical Oncology (11)
  5. Clinical Cancer Research (9)
  6. Cancer Discovery (6)

More Publications

Publishers
  1. American Association for Cancer Research (34)
  2. Nature Publishing Group (30)
  3. American Society of Hematology (18)
  4. American Society of Clinical Oncology (13)
  5. Cell Press (12)
  6. Nature Research (4)

More Publishers

Results (143)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
    Journal Article

    Lee, W.; Teckie, S.; Wiesner, T.; Ran, L.; Prieto Granada, C. N.; Lin, M.; Zhu, S.; Cao, Z.; Liang, Y.; Sboner, A.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis
    Journal Article

    Ortiz, B.; Fabius, A. W. M.; Wu, W. H.; Pedraza, A.; Brennan, C. W.; Schultz, N.; Pitter, K. L.; Bromberg, J. F.; Huse, J. T.; Holland, E. C.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2014)

    Fulltext@MSK | Save
  • Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence
    Journal Article

    Nissan, M. H.; Pratilas, C. A.; Jones, A. M.; Ramirez, R.; Won, H.; Liu, C.; Tiwari, S.; Kong, L.; Hanrahan, A. J.; Yao, Z.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Genome-wide analysis of the role of copy-number variation in pancreatic cancer risk
    Journal Article

    Willis, J. A.; Mukherjee, S.; Orlow, I.; Viale, A.; Offit, K.; Kurtz, R. C.; Olson, S. H.; Klein, R. J.
    Frontiers in Genetics (2014)

    Fulltext@MSK | Save
  • High-throughput mutational profiling of post-myeloproliferative neoplasm acute myeloid leukemia reveals frequent mutations in NRAS in JAK2V617F-negative post-MPN AML
    Meeting Abstract

    Rampal, R. K.; Devlin, S. M.; McKenney, A. S.; Knapp, K. M.; Patel, M.; Wang, K.; Nahas, M. K.; Yelensky, R.; Otto, G. A.; Lipson, D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Heterodimeric JAK STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Journal Article

    Koppikar, P.; Bhagwat, N.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Hricik, T.; Liu, F.; Saunders, L. M.; Mullally, A.; Abdel-Wahab, O.; more...
    Nature (2012)

    Fulltext@MSK | Save
  • A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival
    Journal Article

    Willis, J. A.; Olson, S. H.; Orlow, I.; Mukherjee, S.; McWilliams, R. R.; Kurtz, R. C.; Klein, R. J.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • IDH mutation and neuroglial developmental features define distinct subclasses of lower-grade diffuse astrocytic glioma
    Meeting Abstract

    Gorovets, D.; Kannan, K.; Shen, R. L.; Kastenhuber, E.; Chan, T.; Huse, J.
    Journal of Neuropathology and Experimental Neurology (2012)

    Fulltext@MSK | Save
  • IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma
    Journal Article

    Gorovets, D.; Kannan, K.; Shen, R.; Kastenhuber, E. R.; Islamdoust, N.; Campos, C.; Pentsova, E.; Heguy, A.; Jhanwar, S. C.; Mellinghoff, I. K.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Meeting Abstract

    Bhagwat, N.; Koppikar, P.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Mullally, A.; Abdel-Wahab, O.; Leung, L.; Weinstein, A.; Marubayashi, S.; more...
    Blood (2011)

    Fulltext@MSK | Save